文献
J-GLOBAL ID:202202285865713681
整理番号:22A0439459
アブレーション療法で治療した中間リスク前立腺癌における予測尺度としての4年間の前立腺特異抗原応答率:SPRAT分析【JST・京大機械翻訳】
Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis
著者 (11件):
Glicksman R.M.
(Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada)
,
Kishan A.U.
(Department of Radiation Oncology, University of California, Los Angeles, California, USA)
,
Katz A.J.
(St. Francis Hospital, Roslyn, New York, USA)
,
Mantz C.A.
(21st Century Oncology, Fort Myers, Florida, USA)
,
Collins S.P.
(Department of Radiation Oncology, Georgetown University, Washington, DC, USA)
,
Fuller D.B.
(Division of Genesis Healthcare Partners Inc, Cyberknife Centres of San Diego Inc, San Diego, California, USA)
,
Steinberg M.L.
(Department of Radiation Oncology, University of California, Los Angeles, California, USA)
,
Shabsovich D.
(Department of Radiation Oncology, University of California, Los Angeles, California, USA)
,
Zhang L.
(Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada)
,
Loblaw A.
(Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada)
,
Loblaw A.
(Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada)
資料名:
Clinical Oncology
(Clinical Oncology)
巻:
34
号:
1
ページ:
36-41
発行年:
2022年
JST資料番号:
W3200A
ISSN:
0936-6555
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)